FAS and toxic epidermal necrolysis: In 1998, Viard et al. demonstrated that IVIg may block Fas-mediated keratinocyte death in vitro, and they also found that IVIg interrupted disease progression and improved prognosis in a cohort of 10 TEN patients [8].